EUCTR2005-005048-19-IT
Active, not recruiting
Not Applicable
A phase II randomised study to investigate the effects of Bevacizumab on cell proliferation and on pCR in patients with locally advanced operable breast cancer - ND
DrugsAVASTIN
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ISTITUTO EUROPEO DI ONCOLOGIA
- Enrollment
- 120
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with histologically proven primary breast cancer 2\.0 cm, T2\-T3 T4 a\-d, N0\-2, M0 Women aged 18 70 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Patients with overexpression HER2/neu 3 or amplification of HER2/neu gene evaluated by FISH, suitable for Herceptin containing regimens as primary therapy Patients with other non\-malignant uncontrolled systemic diseases that would preclude trial entry in the opinion of the investigator. Specifically not eligible are patients with uncontrolled active infection, chronic infection such as active HBV or HCV INR greater than 1\.50\. Prior history of bleeding diathesis or coagulopathy including deep venous thrombosis or pulmonary embolism. Recent within last six months or current history of gastrointestinal bleeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A randomised phase II study to evaluate the effectiveness of botulinum toxin to delay, and possibly prevent, progressive foot deformities in children with Charcot-Marie-Tooth (CMT) disease.Charcot-Marie-Tooth diseaseHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersNeurological - Other neurological disordersACTRN12605000115639The Children's Hospital at Westmead10
Recruiting
Phase 1
Effects of natural seaweed extract (GFS) on mobilisation of human bone marrow stem cells and immune system activatioormal volunteersNormal volunteersOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveInflammatory and Immune System - Normal development and function of the immune systemACTRN12605000021673Tas100
Recruiting
Phase 2
Phase II randomized study to investigate the effectiveness of Hangeshashinto(TJ-14) against chemoradiation-induced oral and pharyngeal mucositishead and neck cancerJPRN-UMIN000012948Department of Otolaryngolory-Head and Neck Surgery, National Defense Medical College of Japan90
Not yet recruiting
Phase 2
A randomised phase 2 study of carboplatin with oral vinorelbine followed by maintenance therapy with oral vinorelbine or erlotinib in elderly patients with metastatic non-small cell lung cancer.on Small Cell Lung CancerNon Small Cell Lung CancerCancer - Lung - Non small cellACTRN12612000473864Southern Health100
Active, not recruiting
Not Applicable
A phase 2 randomised trial to investigate the effects of recombinant human erythropoietin on infarct size in patients undergoing primary percutaneous coronary angiography for ST-segment elevation myocardial infarction. - Erythropoietin in acute MIAcute ST elevation myocardial infarctionMedDRA version: 9.1Level: LLTClassification code 10000891Term: Acute myocardial infarctionEUCTR2004-005259-32-GBImperial College Heathcare NHS Trust